RSPO4
Basic information
Region (hg38): 20:958452-1002311
Previous symbols: [ "C20orf182" ]
Links
Phenotypes
GenCC
Source:
- nonsyndromic congenital nail disorder 4 (Definitive), mode of inheritance: AR
- nonsyndromic congenital nail disorder 4 (Strong), mode of inheritance: AR
- nonsyndromic congenital nail disorder 4 (Supportive), mode of inheritance: AR
- nonsyndromic congenital nail disorder 4 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Anonychia/hyponychia congenita | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Dermatologic | 4702713; 17186469; 17041604; 17914448; 18070203; 22300369 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (2 variants)
- Anonychia (1 variants)
- Inborn genetic diseases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RSPO4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 23 | 27 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 2 | 0 | 24 | 4 | 2 |
Highest pathogenic variant AF is 0.000131
Variants in RSPO4
This is a list of pathogenic ClinVar variants found in the RSPO4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
20-960371-C-T | Inborn genetic diseases | Uncertain significance (Dec 14, 2023) | ||
20-960381-C-T | RSPO4-related disorder | Likely benign (Apr 29, 2019) | ||
20-960382-G-T | Inborn genetic diseases | Uncertain significance (Feb 21, 2024) | ||
20-960389-C-G | Inborn genetic diseases | Uncertain significance (Sep 20, 2023) | ||
20-960401-G-A | Inborn genetic diseases | Uncertain significance (Oct 05, 2023) | ||
20-960428-G-A | Inborn genetic diseases | Uncertain significance (May 08, 2023) | ||
20-960442-C-T | Inborn genetic diseases | Uncertain significance (Jan 23, 2024) | ||
20-963952-T-C | Inborn genetic diseases | Likely benign (Jan 29, 2024) | ||
20-963959-G-A | RSPO4-related disorder | Benign (Oct 28, 2019) | ||
20-963960-A-C | Inborn genetic diseases | Uncertain significance (Feb 22, 2023) | ||
20-963983-C-G | Inborn genetic diseases | Uncertain significance (May 16, 2024) | ||
20-964004-C-T | Inborn genetic diseases | Uncertain significance (Jun 28, 2022) | ||
20-964054-G-A | Inborn genetic diseases | Uncertain significance (Mar 12, 2024) | ||
20-964072-T-C | Inborn genetic diseases | Uncertain significance (Dec 13, 2023) | ||
20-964075-T-G | Inborn genetic diseases • RSPO4-related disorder | Uncertain significance (Nov 22, 2023) | ||
20-964094-C-T | Inborn genetic diseases | Likely benign (Mar 15, 2023) | ||
20-964098-C-A | Inborn genetic diseases | Uncertain significance (Sep 14, 2022) | ||
20-964106-C-T | Inborn genetic diseases | Uncertain significance (Aug 30, 2022) | ||
20-967186-G-A | Inborn genetic diseases | Uncertain significance (Sep 06, 2022) | ||
20-967216-G-A | Inborn genetic diseases | Uncertain significance (Apr 17, 2024) | ||
20-967223-G-A | RSPO4-related disorder | Likely benign (Sep 05, 2019) | ||
20-967230-C-T | Anonychia | Pathogenic (Nov 01, 2006) | ||
20-967244-CAAGT-C | Anonychia | Pathogenic (Apr 23, 2024) | ||
20-967245-A-G | Inborn genetic diseases | Uncertain significance (Aug 30, 2021) | ||
20-967249-A-G | Inborn genetic diseases | Uncertain significance (Apr 12, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RSPO4 | protein_coding | protein_coding | ENST00000217260 | 5 | 43813 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
8.60e-8 | 0.170 | 124769 | 0 | 28 | 124797 | 0.000112 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.470 | 166 | 150 | 1.11 | 0.0000100 | 1491 |
Missense in Polyphen | 68 | 55.143 | 1.2332 | 542 | ||
Synonymous | -1.02 | 70 | 59.9 | 1.17 | 0.00000373 | 458 |
Loss of Function | 0.0796 | 11 | 11.3 | 0.974 | 5.86e-7 | 121 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000395 | 0.000381 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000223 | 0.000223 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000979 | 0.0000971 |
Middle Eastern | 0.000223 | 0.000223 |
South Asian | 0.000196 | 0.000196 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Activator of the canonical Wnt signaling pathway by acting as a ligand for LGR4-6 receptors. Upon binding to LGR4-6 (LGR4, LGR5 or LGR6), LGR4-6 associate with phosphorylated LRP6 and frizzled receptors that are activated by extracellular Wnt receptors, triggering the canonical Wnt signaling pathway to increase expression of target genes. Also regulates the canonical Wnt/beta-catenin-dependent pathway and non-canonical Wnt signaling by acting as an inhibitor of ZNRF3, an important regulator of the Wnt signaling pathway. {ECO:0000269|PubMed:21727895, ECO:0000269|PubMed:21909076}.;
- Disease
- DISEASE: Nail disorder, non-syndromic congenital, 4 (NDNC4) [MIM:206800]: A nail disorder characterized by congenital anonychia or its milder phenotypic variant hyponychia. Anonychia/hyponychia is the absence or severe hypoplasia of all fingernails and toenails without significant bone anomalies. {ECO:0000269|PubMed:17041604}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Signaling by WNT;Signal Transduction;Regulation of FZD by ubiquitination;TCF dependent signaling in response to WNT
(Consensus)
Recessive Scores
- pRec
- 0.138
Intolerance Scores
- loftool
- 0.297
- rvis_EVS
- 0.31
- rvis_percentile_EVS
- 72.38
Haploinsufficiency Scores
- pHI
- 0.199
- hipred
- N
- hipred_score
- 0.238
- ghis
- 0.419
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 2.22e-16
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rspo4
- Phenotype
Gene ontology
- Biological process
- Wnt signaling pathway;positive regulation of Wnt signaling pathway;nail development;positive regulation of canonical Wnt signaling pathway
- Cellular component
- extracellular region;extracellular space
- Molecular function
- frizzled binding;heparin binding